Evogene

Company Overview

Snapshot

Founded in January 2002 by Rafi Meissner and Hagai Karchi, Evogene operates with 51–200 employees. The company has raised $135.7M across 10 funding rounds from 9 investors. In October 2024, Evogene announced a collaboration with Google Cloud to develop a generative AI foundation model for novel small molecule design.

Business overview

Evogene is a computational biology company that leverages its proprietary Computational Predictive Biology (CPB) platform to accelerate product discovery and development across various life sciences industries. The platform integrates deep biological understanding with big data and artificial intelligence to computationally discover and guide the development of life sciences products based on microbes, small molecules, and genetic elements. Evogene and its subsidiaries are advancing product pipelines in human microbiome-based therapeutics, medical cannabis, agricultural biologicals, agriculture chemicals, and agricultural solutions for castor oil production, serving markets within Health Tech & Life Sciences and Agriculture & Food Technologies.

Strategic signal

In October 2024, Evogene announced a collaboration with Google Cloud to pioneer a generative AI foundation model for novel small molecule design. This strategic partnership signals a significant advancement in Evogene's computational biology capabilities, leveraging cutting-edge AI to enhance its discovery platform and potentially accelerate the development of new products in life sciences, offering a strong growth catalyst for investors.

Company Intelligence Q&A

What was a significant recent collaboration for Evogene?

In October 2024, Evogene announced a collaboration with Google Cloud to develop a generative AI foundation model for novel small molecule design, aiming to revolutionize life-science-based product discovery.

What was a key operational milestone for Casterra, an Evogene subsidiary, in Africa?

In October 2024, Casterra, an Evogene subsidiary, announced the completion of its first shipment of castor seeds grown and processed in Kenya, marking a key milestone in its operational expansion plan in Africa.

What grant did Lavie Bio, an Evogene subsidiary, receive in September 2024?

In September 2024, Lavie Bio received a grant from the Israel Innovation Authority to advance the development of 'MicroFermentor', a unique technology designed to improve the economics of ag-biologicals.

What was the outcome of the collaboration between Watershed AC, Evogene, and Ben-Gurion University in October 2024?

In October 2024, Watershed AC, Evogene, and Ben-Gurion University received approval for a second-year grant to continue their collaboration focused on improving crustacean traits using gene editing technology.

When did Evogene last report its third-quarter financial results?

Evogene reported its third-quarter 2024 financial results in November 2024, discussing challenges and opportunities during its earnings call.